CTRI/2023/05/053343尚未招募Unknown
ASSESSMENT OF GESTATIONAL DIABETES MELLITUS AMONG FIRST TRIMESTER PREGNANT WOMEN - A COMMUNITY BASED CROSS SECTIONAL STUDY
Dr AKSHATA CHIKALI0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. PREGNANT WOMEN RESIDING IN FIELD PRACTICE AREA WHO ARE WILLING TO PARTICIPATE IN THE STUDY AND WILL BE ABLE TO GIVE INFORMED CONSENT
- •2. WITH SINGLETON PREGNANCY
- •3. PREGNANCY REGISTERED BEFORE 13 WEEK OF GESTATIONAL AGE
排除标准
- •1. KNOWN HISTORY OF DIABETES MELLITUS
- •2. KNOWN HISTORY OF CHRONIC KIDNEY DISEASE, CHRONIC PANCREATITIS, AND OTHER SEVERE ILLNESSES
- •3. WOMEN WHO ARE CURRENTLY TAKING MEDICATIONS THAT MAY AFFECT GLUCOSE METABOLISM (E.G. GLUCOCORTICOIDS, ANTIPSYCHOTICS, ETC)
研究者
相似试验
尚未招募
不适用
Study on the effects of an infant formula on stool in healthy infantsNL-OMON19941FrieslandCampina300
进行中（未招募）
不适用
A randomized, placebo-controlled, double-blind phase II study evaluating if Glucophage can avoid Liver injury due to Chemotherapy Associated Steatosis.first-line palliative treated, KRAS-Wild-Type, metastatic colorectal cancerEUCTR2011-001010-34-ATABCSG (Austrian Breast & Colorectal Cancer Study Group)132
已完成
3 期
A double-blind, randomised, placebo-controlled multicenter study to asses the safety and efficacy of AST-120 in mild to moderately active Crohn's patients with fistulas.inflamattory bowel dissease10017969NL-OMON30808Ocera Therapeutics, Inc.9
进行中（未招募）
1 期
A randomised, controlled with placebo, double blind, double dummy, parallel group study on the therapeutic efficacy and safety of Beclomethasone dipropionate (BDP) in the treatment of patients with post-active Crohn’s Ileitis with remission induced by a course of systemic steroid - N/AActive Crohn's ileitisMedDRA version: 6Level: highClassification code 10011401EUCTR2004-001109-81-CZChiesi Farmaceutici SpA320
进行中（未招募）
不适用
Study with the herbal preparation STW5-II in patients with mild to moderate ulcerative colitis (chronic inflammatory bowel disease)lcerative colitisEUCTR2013-000891-13-DESteigerwald Arzneimittelwerk GmbH